Perspective Therapeutics ...

AMEX: CATX · Real-Time Price · USD
3.58
-0.32 (-8.21%)
At close: Aug 15, 2025, 3:59 PM
3.67
2.66%
After-hours: Aug 15, 2025, 05:01 PM EDT

Perspective Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-66.99M -85.17M -79.28M -63.78M -59.02M -58.42M -46.51M -25.9M -19.61M -10.59M -11.56M -9.1M -7.27M -6.25M -5.65M -4.92M -3.39M -3.51M
Depreciation & Amortization
3.31M 2.69M 2.31M 1.85M 1.44M 1.11M 946K 767K 576K 396K 280K 257K 248K 225K 197K 174K 149K 141K
Stock-Based Compensation
10.61M 6.83M 5.39M 4.05M 2.55M 3.03M 3.74M 3.17M 3.19M 2.14M 930K 956K 1.09M 1.06M 996K 897K 386K 479K
Other Working Capital
-2.38M -2.31M 27.42M 25.6M 27.28M 26.78M 721K 1.31M 267K 975K 1.12M 558K 714K 106K -253K 322K 100K 282K
Other Non-Cash Items
5.31M 22.99M 23.57M 4.12M 4.67M 4.65M 4.96M 2.29M 2.19M 2.22M 2.2M 26K 77K 76K 74K 72K 72K 71K
Deferred Income Tax
-9.95M -2.1M -2.1M 7.85M 7.86M 8.16M -2.34M -10.19M -10.2M -10.5M n/a n/a n/a n/a 3K 10K 10K 10K
Change in Working Capital
-936K 1.03M 31.81M 45.23M 28.33M 28.13M 2.3M -933K 1.42M -942K -814K 469K -1.85M -1.04M -753K -819K -67K 246K
Operating Cash Flow
-58.65M -53.72M -18.29M -696K -14.17M -13.34M -36.91M -30.8M -22.45M -17.27M -8.97M -7.39M -7.71M -5.94M -5.14M -4.58M -2.84M -2.57M
Capital Expenditures
-53.79M -50M -54.41M -39.89M -10.4M -9.94M -1.07M -1.09M -951K -501K -326K -302K -266K -276K -343K -322K -381K -291K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 2.7M 2.7M 2.7M 2.7M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-254.48M -227.89M -243.51M -78.73M -78.73M -38.23M -25.46M -25.46M -60.54M -60.54M -70.15M -70.15M -35.08M -35.08M n/a n/a n/a n/a
Sales Maturities Of Investments
133.73M 100.43M 78.73M 38.23M 38.23M n/a 22.76M 22.76M 22.76M 22.76M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
227K 254K 263K -24K n/a -18K -18K -36K -36K -36K 35.04M 35.06M 35.06M 35.05M -29K -29K -29K -20K
Investing Cash Flow
-174.32M -177.2M -218.93M -80.42M -50.91M -48.19M 24.37M 24.34M -10.6M -10.15M -35.44M -35.4M -284K -299K -372K -351K -410K -311K
Debt Repayment
-41K -49K -48K -48K -32K -24K -12K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
22.13M -100.05M 13.15M 898K 254K 113.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a 243K 8.31M 8.31M
Financial Cash Flow
20.19M 133.03M 289.38M 289.39M 288.76M 167.19M 785K 433K 460K -52K 56K 112K 84K 327K 56.27M 56.46M 112.44M 113.07M
Net Cash Flow
-188.35M -97.89M 61.58M 217.7M 233.1M 115.08M -11.76M 33.89M 7.33M 12.45M -4.46M -42.7M -7.94M -5.94M 50.77M 59.75M 61.44M 62.44M
Free Cash Flow
-112.45M -103.72M -72.71M -40.59M -24.57M -23.29M -37.98M -31.88M -23.4M -17.77M -9.29M -7.69M -7.98M -6.21M -5.48M -4.91M -3.22M -2.86M